Synergy CHC (NASDAQ:SNYR) Releases Quarterly Earnings Results

Synergy CHC (NASDAQ:SNYR) announced its earnings results on Wednesday. The company reported ($1.54) earnings per share for the quarter, FiscalAI reports. The firm had revenue of $6.07 million for the quarter. Synergy CHC had a negative return on equity of 19.51% and a net margin of 7.77%.

Here are the key takeaways from Synergy CHC’s conference call:

• Beverage momentum in early 2026 — management reports >$600,000 of gross revenue year-to-date in Q1 2026 (surpassing all of 2025) and a ~ $2.5M run-rate, with major new distribution placements and millions of cans in stock ready to ship.
• Large one-time charges drove the quarterly and annual losses — the company recorded an allowance for bad debt (~$6.66M), reversal/termination of international license revenue (~$2.9M), obsolete inventory write-off (~$1.04M), and prepaid media write-off (~$0.9M), which materially reduced Q4 and full-year results and adjusted EBITDA.
• Retail execution and growth initiatives — shipped new supplement SKUs to all ~1,600 Kroger locations and began shipments to Costco de México after forming a Mexican subsidiary, plus plans to restart TV advertising (management expects ~15% same-store lift).
• Balance sheet and working capital mixed picture — cash increased to $2.6M and working capital moved to a $1.78M surplus, but inventory rose to $3.7M and total liabilities remained roughly flat at ~$33M, leaving liquidity and execution risks to monitor.

Synergy CHC Price Performance

Shares of Synergy CHC stock traded down $0.24 during trading on Wednesday, reaching $1.05. 42,427 shares of the company traded hands, compared to its average volume of 26,538. The firm has a market capitalization of $11.81 million, a PE ratio of 3.62 and a beta of 3.63. Synergy CHC has a 1-year low of $0.71 and a 1-year high of $4.08. The company has a 50 day moving average price of $1.50 and a 200-day moving average price of $1.91.

Institutional Investors Weigh In On Synergy CHC

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Heartland Advisors Inc. bought a new position in shares of Synergy CHC during the 3rd quarter worth about $1,342,000. Geode Capital Management LLC grew its stake in shares of Synergy CHC by 29.9% in the 4th quarter. Geode Capital Management LLC now owns 36,038 shares of the company’s stock valued at $67,000 after buying an additional 8,288 shares during the period. XTX Topco Ltd bought a new stake in Synergy CHC in the 2nd quarter valued at about $57,000. DRW Securities LLC acquired a new position in Synergy CHC during the 4th quarter worth approximately $36,000. Finally, Virtu Financial LLC acquired a new position in Synergy CHC during the 3rd quarter worth approximately $38,000.

Analysts Set New Price Targets

Several research firms have recently weighed in on SNYR. Ascendiant Capital Markets started coverage on Synergy CHC in a research report on Monday, February 2nd. They issued a “buy” rating and a $5.00 price objective for the company. Weiss Ratings restated a “hold (c-)” rating on shares of Synergy CHC in a research report on Friday. Two research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $6.00.

Synergy CHC Company Profile

Synergy CHC Corp. engages in the marketing and distribution of branded health and wellness products. The company was founded on December 29, 2010 and is headquartered in Westbrook, ME.